Skip to main content
S 2151 105th Congress Senate Crime and Law Enforcement Administrative procedure Administrative remedies Assisted suicide Commerce Department of Justice Drug abuse Drug industry Drug law enforcement Drug utilization Drugs Euthanasia Evidence (Law) Executive reorganization Federal advisory bodies Government Operations and Politics Health Law Licenses Pain

Lethal Drug Abuse Prevention Act of 1998

Introduced: June 9, 1998 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 9 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 14, 1998
Sponsor introductory remarks on measure. (CR S12492-12493)
Oct 6, 1998
By Senator Hatch from Committee on Judiciary filed written report. Report No. 105-372. Additional and minority views filed.
Sep 24, 1998
Placed on Senate Legislative Calendar under General Orders. Calendar No. 607.
Sep 24, 1998
Committee on Judiciary. Reported to Senate by Senator Hatch with an amendment in the nature of a substitute and an amendment to the title. Without written report.
Sep 24, 1998
Committee on Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
Jul 31, 1998
Committee on the Judiciary. Hearings held. Hearings printed: S.Hrg. 105-974.
Jun 9, 1998
Read twice and referred to the Committee on Judiciary.
Jun 9, 1998
Sponsor introductory remarks on measure. (CR S5797-5798)
Jun 9, 1998
Introduced in Senate
 Plain-English summary Congressional Research Service

Lethal Drug Abuse Prevention Act of 1998 - Amends the Controlled Substances Act (CSA) to require the Attorney General to determine that registration of an applicant to manufacture, distribute, conduct research with, or dispense specified controlled substances or listed chemicals is inconsistent with the public interest if: (1) during the five-year period immediately preceding submission of the application, the applicant's registration was revoked; or (2) the Attorney General determines, based on clear and convincing evidence, that the applicant is applying for the registration with the intention of using such registration to violate CSA provisions.

Authorizes the Attorney General to suspend or revoke a registration upon a finding that the registrant has intentionally dispensed or distributed a controlled substance with a purpose of causing, or assisting in causing, the suicide, euthanasia, or mercy killing of any individual.

Directs the Attorney General to establish the Medical Review Board on Pain Relief, which, based on a hearing, shall make findings regarding whether a particular action at issue is an appropriate means to relieve pain that does not constitute a violation of such provision.

What's happening now October 14, 1998

Sponsor introductory remarks on measure. (CR S12492-12493)

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Republican 1